|
a) Bergman, J.; Egestad, B.; Lindstrom, J.-O. The structure of some indolic constituents in Couroupita Guaianensis Aubl. Tetrahedron Lett., 1977, 30, 2625-2626.; b) Mitscher, L. A.; Wong, W.-C.; DeMeulenaere, T.; Sulko, J.; Drake, S. Antimicrobial agents from higher plants. New synthesis and bioactivity of tryptanthrin (indolo-[2,1-b]-quinazolin-6,12-dione) and its analogues. Heterocycle, 1981, 15 (2), 1017-1021; c) Jarrah, M. Y.; Thaller, V. 300MHz Hnmr spectra of indolo[2,1-b] quinazoline-6,12-dione, tryptanthrine and its 2- and 8-chloro-derivatives. J. Chem. Res. (S), 1980, 186; d) Brufani, M.; Fedeli, W.; Mazza, F.; Gerhard, A.; Keller-Schierlein, W. The structure of tryptanthrin. Experientia, 1971, 27, 1249-1250.
Mitscher, L. A. and Baker, W. A search for novel chemotherapy against tuberculosis amongst natural products. Pure&Appl. Chem. 1998, 70(2), 365-371.
Wall, M. E.; Wanai, M. C.; Cook, C. E.; Palmer, K. H.; McPhail, A. T.; Sim, G. A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitors from Camptotheca acuminata. J. Am. Chem. Soc., 1966, 88, 3888-3890.
Woodward, R. B.; Iacobucci, G. A.; Hochstein, F. A. The synthesis of ellipticine. J. Am. Chem. Soc. 1959, 81, 4434-4435.
Meegalla, S. K.; Stevens, G. J.; McQueen, C. A.; Chen, A. Y.; Yu, C.; Liu, L. F.; Barrows, L. R.; LaVoie, E. J. Synthesis and pharmacological evaluation of isoindolo[2,1-b]quinazolinone and isoindolo[2,1-a]benzimidazole derivatives related to the antitumor agent batracylin. J. Med. Chem. 1994, 37, 3434-3439.
Kuo, S.-C.; Lee, H.-Z.; Juang, J.-P.; Lin, Y.-T.; Wu, T.-S.; Chang, J.-J.; Lendnicer, D.; Paul, K. D.; Lin, C. M.; Hamel, E.; Lee, K.-H. Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4''''-substituted phenyl)-4-quinazolones and related compounds: identification as antimitotic agents interacting with tubulin. J. Med. Chem. 1993, 36, 1146-1156.
Meegalla, S. K.; Stevens, G. J.; McQueen, C. A.; Chen, A. Y.; Yu, C.; Liu, L. F.; Barrows, L. R. and LaVoie, E. J. Synthesis and pharmacological evaluation of isoindolo[2,1-b]quinazolinone and isoindolo[2,1-a]benzimidazole derivatives related to the antitumor agent batracylin. J. Med. Chem. 1994, 37, 3434-3439.
Brufani, M. B.; Fedeli, W.; Mazza, F.; Gerhard, A. and Keller-Schierlein, W. The structure of tryptanthrin. Experientia 1971, 27, 11, 1-2.
(a) Pilch, D. S.; Martin, M.-T.; Nguyen, C. H.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Self-association and DNA-binding properties of two triple helix-specific ligands: comparison of a benzo[e]pyridoindole and a benzo[g]pyridoindole. J. Am. Chem. Soc. 1993, 115, 9942-9951; (b) Escude, C.; Nguyen, C. H.; Mergny, J.-L.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Selective stabilization of DNA triple helices by benzopyridoindole derivatives. ibid. 1995, 10212-10219; (c) Nguyen, C. H.; Marchand, C.; Delage, S.; Sun, J.-S.; Garestier, T.; Helene, C. and Bisagni, E. Synthesis of 13H-benzo[6,7]- and 13H-benzo[4,5]indolo[3,2-c]-quinolines: A new series of potent specific ligands for triplex DNA. ibid. 1998, 120, 2501-2507.
(a) Pilch, D. S.; Martin, M.-T.; Nguyen, C. H.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Self-association and DNA-binding properties of two triple helix-specific ligands: comparison of a benzo[e]pyridoindole and a benzo[g]pyridoindole. J. Am. Chem. Soc. 1993, 115, 9942-9951; (b) Escude, C.; Nguyen, C. H.; Mergny, J.-L.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Selective stabilization of DNA triple helices by benzopyridoindole derivatives. ibid. 1995, 10212-10219; (c) Nguyen, C. H.; Marchand, C.; Delage, S.; Sun, J.-S.; Garestier, T.; Helene, C. and Bisagni, E. Synthesis of 13H-benzo[6,7]- and 13H-benzo[4,5]indolo[3,2-c]-quinolines: A new series of potent specific ligands for triplex DNA. ibid. 1998, 120, 2501-2507.
Mergny, J. L.; Duval-Valentin, G.; Nguyen, C. H.; Perouault, L.; Faucon, B.; Rougee, M. Montenay-Garestier, T.; Bisagni, E. and Helene, C. Triple helix-specific ligands. Science, 1992, 256, 19, 1681-1684.
Friedlander, P.; Roschdestwensky, N.Ber. 1915, 48, 1841.
Brid, C.W. The structure of methylistoid. Tetrahedron, 1963, 19, 901-904.
Kikumoto, R.; Kobayashi, T. The reaction of oxindoles and isatin with mitrobenzyl chlorides. Tetradron, 1966, 22, 3337-3343.
Mitscher, L. A.; Wong, W-C.; DeMeulenaere, T.; Sulko, J.; Drake, S. Antimicrobial agents from higher plants. New synthesis and bioactivity of tryptanthrin (indolo[2,1-b]-quinazolin-6,12-dione) and its analogues. Heterocycle, 1981, 15(2), 1017-1021.
Bergman, J.; Egestad, B.; Lindstrom, J-O. The structure of some indolic constituents in Couroupita Guaianensis Aubl, Tetrahedron Lett. 1977, 30, 2625-2626.
Cheng, C. C. Structural aspectecs of antineoplastic agents-a new approach. Progress Med. Chem. 1988, 25, 36-83.
Wall, M. E.; Wanai, M. C.; Cook, C. E.; Palmer, K. H.; McPhail, A. T.; Sim, G. A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitors from Camptotheca acuminata. J. Am. Chem. Soc., 1966, 88, 3888-3890.
Woodward, R. B.; Iacobucci, G. A.; Hochstein, F. A. The synthesis of ellipticine. J. Am. Chem. Soc. 1959, 81, 4434-4435.
a) Zee-Cheng, R. K. Y.; Cheng, C. C., Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones., J. Med. Chem., 1978, 21(3), 291-294; b) Cheng, C. C.; Dong, Q.; Liu, D-F.; Luo, Y-l.; Liu, L. F.; Chen, A. Y.; Yu, C.; Savaraj, N.; Chou, T-C,, Design of antineoplastic agents on the basis of the Ŗ-phenylnaphthalene-type" benzo[b]naphtho[2,3-d] furan-6,11-dione derivatives., J. Med. Chem., 1993, 36(25), 4108-4112.
Meegalla, S. K.; Stevens, G. J.; McQueen, C. A.; Chen, A. Y.; Yu, C.; Liu, L. F.; Barrows, L. R.; LaVoie, E. J. Synthesis and pharmacological evaluation of isoindolo[2,1-b]quinazolinone and isoindolo[2,1-a]benzimidazole derivatives related to the antitumor agent batracylin. J. Med. Chem. 1994, 37, 3434-3439.
Kuo, S.-C.; Lee, H.-Z.; Juang, J.-P.; Lin, Y.-T.; Wu, T.-S.; Chang, J.-J.; Lendnicer, D.; Paul, K. D.; Lin, C. M.; Hamel, E.; Lee, K.-H. Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4''''-substituted phenyl)-4-quinazolones and related compounds: identification as antimitotic agents interacting with tubulin. J. Med. Chem. 1993, 36, 1146-1156.
Mucci-LoRusso, P.; Polin, L.; Bissery, M.-C.; Valeriote, F.; Polwman, J.; Luk, G. D.; Corbett, T. H. Activity of batracylin (NSC-320846) against solid tumors of mice. Invest. New Drugs, 1989, 7, 295-306.
Waud, W. R.; Harrison, Jr. S. D.; Gilbert, K. S.; Laster, W. R. and Griswold, Jr. D. P. Antitumor drud cross-resistance in vivo in a cisplatin-rresistant murine P388 leukemia. Cancer Chemother. Pharmacol. 1991, 27, 456-463.
Meegalla, S. K.; Stevens, G. J.; McQueen, C. A.; Chen, A. Y.; Yu, C.; Liu, L. F.; Barrows, L. R. and LaVoie, E. J. Synthesis and pharmacological evaluation of isoindolo[2,1-b]quinazolinone and isoindolo[2,1-a]benzimidazole derivatives related to the antitumor agent batracylin. J. Med. Chem. 1994, 37, 3434-3439.
(a) Jiang, J. B.; Hesson, D. P.; Dusak, B. A.; Dexter, D. L.; Kang, G. J.; Hamel, E. Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-one, a new class of antimitoic anticancer agents which inhibit tubulin polymerization. J. Med. Chem. 1990, 33, 1721-1728. (b) Lin, C. M.; Singh, S. B.; Chu, P. S.; Dempcy, R. O.; Schmidt, J. M.; Pettit, G. R.; Hamel, E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure activity study. Mol. Pharmacol. 1998, 34, 200-208.
Batra, J. K.; Powers, L. J.; Hess, F. D.; Hamel, E. Derivatives of 5,6-dipheylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site. Cancer Research, 1986, 46, 1889-1893.
Huang, T. S.; Lee, S. C. and Lin, J. K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 5292-5296.
Liu, J. Y.; Lin, S. J. and Lin, J. K.Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 1993, 14, 857-861.
Brunton, V. G.; Kelland, L. R.; Lear, M. J.; Montgomery, G. J.; Robertson, J. H.; Robins, D. J.; Queen, J. and Workman, P. Synthesis and biological evaluation of a series of tyrphostins containing nitrophene moieties as possible epidermal growth factor receptor tyrosine kinase inbibitor, Anti-Cancer Drug Design, 1996,11,265-295.
Brufani, M. B.; Fedeli, W.; Mazza, F.; Gerhard, A. and Keller-Schierlein, W. The structure of tryptanthrin. Experientia 1971, 27, 11, 1-2.
Nguyen, C. H.; Lhoste, J.-M.; Lavelle, F.; Bissery, M. C.; Bisagni, E. Synthesis and antitumor activity of 1-[[(diakylamino)alkyl]amino]-4-methyl-5H-pyrido [4,3-b] benzo[e]- and -benzo[g]) indoles. A new class of antineoplastic agents. J. Med. Chem. 1990, 33, 1519-1528.
(a) Pilch, D. S.; Martin, M.-T.; Nguyen, C. H.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Self-association and DNA-binding properties of two triple helix-specific ligands: comparison of a benzo[e]pyridoindole and a benzo[g]pyridoindole. J. Am. Chem. Soc. 1993, 115, 9942-9951; (b) Escude, C.; Nguyen, C. H.; Mergny, J.-L.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Selective stabilization of DNA triple helices by benzopyridoindole derivatives. ibid. 1995, 10212-10219; (c) Nguyen, C. H.; Marchand, C.; Delage, S.; Sun, J.-S.; Garestier, T.; Helene, C. and Bisagni, E. Synthesis of 13H-benzo[6,7]- and 13H-benzo[4,5]indolo[3,2-c]-quinolines: A new series of potent specific ligands for triplex DNA. ibid. 1998, 120, 2501-2507.
(a) Pilch, D. S.; Martin, M.-T.; Nguyen, C. H.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Self-association and DNA-binding properties of two triple helix-specific ligands: comparison of a benzo[e]pyridoindole and a benzo[g]pyridoindole. J. Am. Chem. Soc. 1993, 115, 9942-9951; (b) Escude, C.; Nguyen, C. H.; Mergny, J.-L.; Sun, J.-S.; Bisagni, E.; Garestier, T. and Helene, C. Selective stabilization of DNA triple helices by benzopyridoindole derivatives. ibid. 1995, 10212-10219; (c) Nguyen, C. H.; Marchand, C.; Delage, S.; Sun, J.-S.; Garestier, T.; Helene, C. and Bisagni, E. Synthesis of 13H-benzo[6,7]- and 13H-benzo[4,5]indolo[3,2-c]-quinolines: A new series of potent specific ligands for triplex DNA. ibid. 1998, 120, 2501-2507.
Mergny, J. L.; Duval-Valentin, G.; Nguyen, C. H.; Perouault, L.; Faucon, B.; Rougee, M. Montenay-Garestier, T.; Bisagni, E. and Helene, C. Triple helix-specific ligands. Science, 1992, 256, 19, 1681-1684.
Nguyen, C. H.; et al. Futher SAR in the new antitumor 1-amino-substituted g-carbolines and 5H-benzo[e]pyrido[4,3-b] indoles series. Anti-Cancer Drug Design, 1992, 7, 235-251.
(a) Toma, L.; Cignarella, G.; Barlocco, D. and Ronchetti, F. Conformationally constrained congeners of 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones active on the cardiovascular system: conformational studies by molecular mechanics calculations and 1H NMR spectroscopy. J. Med. Chem. 1990, 33, 1591-1594. (b) Barlocco, D.; Cignarella, G.; Montessano, F.; Leonard, A. Mella, M. and Toma, L. Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton. J. Med. Chem. 1999, 42, 173-177.
Cignarella, G.; Barlocco, D.; Bergomi, M.; Menta, E.; Pinna, G. A. and Palumbo, M. Synthesis of new tricyclic indenopyridazines as potential antitumor agents. 26th Nationall Medicinal Cheistry Symposium, 1996.
Cotarca, L.,Delogu, P., Nardelli, A., Sunjic, V.;Bis(trichloromethyl)Carbonate in Organic Synthesis; Synthesis ,1995 , 553-576.
a) Cortez, R.; Rivero, I. A.; Somanathan, R.; Aguirre, G.; Ramirez, F. Synthesis of quinazolinedione using triphosgene. Synthetic Comm., 1991, 21, 2, 285-292. b) Cotarca, L.; Delogu, D.; Nardelli, A.; Sunjic, V.; Bis(trichloromethyl) carbonate in organic synthesis. Synthesis, 1996, 553-576.
Lee, D. G. Oxidation in organic chemistry; Trahanovsky, W. S., Ed.; Academic: New York, 1962; Part D, Chapter 2.
a) Lee, D. G.; Chen, T.; Wang, Z. Heterogeneous permanganate oxidations. 5. The preparation of aldehydes by oxidative cleavage of carbon-carbon double bonds. J. Org. Chem. 1993, 58, 2918; b) Ferreia, J. T. B.; Cruz, W. O.; Vieira, P. C.; Yonashiro, M. Carbon carbon double bond cleavage using solid supported potassium permanganate on silica gel. J. Org. Chem. 1987, 52, 3698.
Sam, D. J.; Simmons, H. E. Crown polyether chemistry. Potassium permanganate oxidations in bezene. J. Am. Chem. Soc., 1972, 94, 4024.
a) Beckwith, A. L. J. Azaisatoic anhydrides. USP. 3947416, 1976.
a) Le Count, D. J.; Dewsbury, D. J. Synthesis of 3-diethylamino-1-ethyl isothiazolo[3,4-b]pyridinium perchlorate and an improved route to 3-azaisatoic anhydride. Synthesis, 1982, 972-973.
Lindwall, H. G.; Bandes, J. and Weinberg, I. Preparation of certain brominated cinchophens. J. Am. Chem. Soc., 1931, 317-319
Submitted by Marvel, C. S. and Hiers, G. S. Checked by Conant, J. B. Isatin. Gilman, H. et al. Ed.; Org. Syn. CV1, 327-330, Organic Syntheses, Inc., 1932.
Meyer, A. I.; Higashiyama, K. Asymmetric additions to chiral naphthalenes. 4. An. Asymmetric synthesis of the AB-ring of aklavinone. J. Org. Chem., 1987, 52, 4592-4597.
Numazama, M.; Nagaoka, M. Stereospecific synthesis of 16a-hydroxy-17-oxo- steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17- ketones and its reaction mechanism. J. Org. Chem., 1982, 47, 4024-4029.
Bergman, J. and Tilstam, U. Structure determintion of candidine, a violet indolic constituent from culture solutions of candida lipolytica; Tetrahedron, 1985, 41, 2883-2884.
Manhas, M. S.; Amin, S. G. and Rao, V. V.; Heterocyclic compounds; IX. A facile synthesis of methaqualone and analogs. Synthesis, 1977, 309-310.
Manhas M. S., Amin S. G. and Rao V. V. Hetercyclic Compounds; IX. A facile synthesis of methaqualone and analogs. Synthesis 1977, 309-310.
a) Laurencd, W. R. Jr.; Frederick, A. G. Jr.; A convenient preparation of 3-methyl-3,4-dihydro-2(1H)-quinazolinone. J. Heterocyclic Chem., 1988, 25, 789-790.; b) Motohiro, A.; Teruyuki, K.; Yashihisa, W.; Transition-metal complex-catalyzed reductive N-heterocyclization: synthesis of 4(3H)- quinazolinone derivatives from N-(2-nitrobenzoyl) amides. J. Org. Chem., 1993, 58, 310-312.
Bech, G.; Bergmann, A.; KeBeler, K.; Wess, G.; Synthesis of a new flavonoid-antioxidant. Tetrahedron Letters, 1990, 31, 50, 7293-7296.
Submitted by Greenwood, F. L.; Kellert, M. D. and Sedlak, J. Checked by Roberts, J. D. and Bottini, A. T. 4-Bromo-2-heptene. Rabjohn, N. et al. Ed.; Org. Syn. CV4, 108-110, Organic Syntheses, Inc., 1963. b) Submitted by Campaigne, E. and Tullar, B. F. Checked by Price, C. C. and Dudley, E. A. 3-Thenyl bromide. Rabjohn, N. et al. Ed.;Org. Syn. CV4, 921-923. Organic Syntheses, Inc., 1963
Guta, C. M.; Bhaduri, A. P.; Khanna, N. M.; Drugs acting on the central nervous system. Synthses of substituted quinazolinones and quinazolines and triazepino- and triazocinoquinazolones. J. Med. Chem., 1968, 11, 392-395.
Kovac, T.; Oklobdzija, M.; Comisso, G.; Decorte, E.; Fajdiga, T.; Moimas, F.; Angeli, C.; Zonno, F.; Toso, R.; Sunjic, V.; New synthesis of 11-acyl-5,11- dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-ones and related studies. J. Heterocyclic Chem., 1983, 20, 1339-1349.
QUANTA 5.0, Molecular Simulations Inc., Burlington, MA.
a) Submitted by Krimmel, C. P.; Thielen, L. E.; Brown, E. A. and Heidtke, W. J. Checked by Johnson, W. S.; Wilds, A. L. and Jellinek, J. S. a,b,b-Tiphenylproponic acid. Rabjohn, N. et al. Ed.; Org. Syn. CV4, 960-962, Organic Syntheses, Inc., 1963. b) Submitted by Schultz, E.M. and Mickey, S. Checked by Cline, E. T. and Schreiber, R. S.a,a-Diphenylacetone. Horning, E. C. et al. Ed.; Org. Syn. CV3, 343-346, Organic Syntheses, Inc., 1955. c) Submitted by Robb, C. M. and Schultz, E. M. Checked by Arnold,, R. T. and Britain, J. W. Diphenylacetonitrile. Horning, E. C. et al. Ed.; Org. Syn. CV3, 347-349, Organic Syntheses, Inc., 1955.
Wolfe, J. F.; Rathman, T. L.; Sleevi, M. C.; Campbell, J. A.; Greenwood, T. D. Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl- 4(3H)-quinazolinones. J. Med. Chem., 1990, 33, 161-166.
Denny, W. A.; Wilson, W. R. Considerations for the design of nitrophenyl mustards as agents with selective toxicityfor hypoxic tumor cells. J. Med. Chem. 1986, 29(6), 879-87,
Staskun, B. New approach to the indolo[2,1-b]quinazoline ring system by cyclization of 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazoline and its m-isomer. Synthesis of the antibiotic tryptanthrin. S. A. fr. J. Chem. 1992, 45, 1, 5-7.
Kikumoto, R. and Kobayashi, T. The reactions of oxindoles and isatin with nitrobenzyl chlorides. Tetrahedron, 1966, 22, 3337-3343.
a) Bergman, J.; Egestad, B.; Lindstrom, J.-O. The structure of some indolic constituents in Couroupita Guaianensis Aubl. Tetrahedron Lett., 1977, 30, 2625-2626.
Cortez, R.; Rivero, I. A.; Somanathan, R.; Aguirre, G.; Ramirez, F. Synthesis of quinazolinedione using triphosgene. Synthetic Comm., 1991, 21 (2), 285-292.
Cotarca, L.; Delogu, D.; Nardelli, A.; Sunjic, V. Bis(trichloromethyl)carbonate in organic synthesis. Synthesis, 1996, 553-576.
Nguyen, C., H.; Lhoste, J.-M.; Lavelle, F.; Bissery, M.-C.; Bisagni, E., Synthesis and antitumor activity of 1-[[(dialkylamino)alkyl]amino]-4-methyl-5H-pyrido [4,3-b]benzo[e]-and -benzo[g]) indoles. A new class of antineoplastic agents. J. Med. Chem., 1990, 33, 1519-1528.
a) Zee-Cheng, R. K. Y.; Cheng, C. C., Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones., J. Med. Chem., 1978, 21, 3, 291-294; b) Cheng, C. C.; Dong, Q.; Liu, D-F.; Luo, Y-l.; Liu, L. F.; Chen, A. Y.; Yu, C.; Savaraj, N.; Chou, T-C. Design of antineoplastic agents on the basis of the Ŗ-phenylnaphthalene-type" benzo[b]naphtha[2,3-d] furan-6,11-dione derivatives., J. Med. Chem., 1993, 36(25), 4108-4112.
a) Le Count, D. J.; Dewsbury, D. J. Synthesis of 3-diethylamino-1- ethylisothiazolo[3,4-b]pyridinium perchlorate and an improved route to 3-azaisatoic anhydride. Synthesis, 1982, 972-973; b) Beckwith, A. L. J. Azaisatoic anhydrides. USP. 3947416, 1976.
Guthrie, R. W.; Kaplan, G. L.; Mennona, F. A.; Tilley, J. W.; Kierstead, R. W.; Mullin, J. G.; LeMahieu, R. A.; Zawoiski, S.; O''''Donnell, M.; Crowley, H.; Yaremko, B.; Welton, A. F., Pentadienyl carboxamine derivatives as antagonists of platelet-activating factor. J. Med. Chem., 1989, 32, 1820-1835.
Ueda, Y.; Chuang, J. M.; Crast. Jr. L. B.; Partyka, R. A.; Synthesis and in vitro activity of new semi-synthetic coumermycin analogs: chemical modification at the C-3 amide. J. Antibiotics, 1989, 1379-1392.
Fisher, M. J.; Gunn, B.; Harms, C. S.; Kline, A. D.; Mullaney, J. T.; Nunes, A.; Scarborough, R. M.; Arfsten, A. E.; Skelton, M. A.; Um, S. L.; Utterback, B. G.; Jakubowski, J. A. Non-peptide RGD surrogates which mimic a Gly-Aspb-turn: potent antagonists of platalet glycoprotein IIb-IIIa. J. Med. Chem., 1997, 40, 2085-2101
Garden, S. J.; Torres, J. C.; Ferreira, A. A.; Silva, R. B.; Pinto, A. C., A modified sandmeyer methodology and the synthesis of (±)-convolutamydine A. Tetrahedron lett. 1997, 38, 9, 1501-1504.
Submitted by Tarbell, D. S. and Fukushima, D. K. Checked by Allen, C. F. H. and Byers, Jr. J. R. m-Thiocresol. (m-toluenethiol; m-tolyl mercaptan) Horning, E. C. et al. Ed.; Org. Syn. CV3, 809-811, Organic Syntheses, Inc., 1955.
Sheradsky, T.; Salemnick, G; Nir, Z. Introduction of the aminooxy group on to nitroaromatic and heterocyclic rings-synthesis and properties of o-(nitroaryl) hydroxylamines. Tetrahedrone, 1972, 28, 3833-3843.
(a) Cronin, T. H.;Hess, H.-J. Some new 3-amino-2H-1,2,4-benzothiadiazine 1,1-dioxides. J. Med. Chem. 1968, 11, (1), 130, 136; (b) Grosso, J. A.; Nichols, D. E.; Kohli, J. D.; Glock, D. Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists. J. Med. Chem. 1982, 25, (6), 703-708.
Adams, R.; Snyder, H. R. seterochemistry of biphenyls XLIII. The effect of substituents in the 4-position of 2-nitro-6-carboxy-2''''-methoxybiphenyl. J. Am. Chem. Soc. 1938, 60, 1411-1413.
(a) Langlois, M.; Soulier, J. L.; Rampillon, V.; Gallais, C.; Bremont, B. et. al. Eur. J. Med. Chem. Chim. Ther. 1994, 29, 12, 925-940. (b) O''''Sullivan; Sadler. J. Chem. Soc. 1957, 2916, 2919-2920.
Crabtree, E. V.; Kramer, D. N. Fluoresence yields of isatoic anhydride from the reasction of N -glyoxyloylanthranilic acid 2-oxime with electrophiles. J. Org. Chem. 1978, 43, 268-272.
(a) Le Count, D. J; Dewsbury, D. J. Synthesis of 3-diethylamino-1-ethylisothiazolo [3,4-b] pyridinium perchlorate and an improved route to 3-azaisatoic anhydride. Synthesis, 1982, 11, 972-973; (b) Sonnenburg, R.; Neda, I.; Fischer, A.; Jones, P. G.; Schmutzler, R. Darstellung von phosphorhltigen heterocyclen aus 2-aminonicotinsaure. Chem. Ber. 1995, 128, 6, 627-634.
(a) Chamot, E. M.; Sherwood, C. M. Studies on the aulture media employed for the bacteriological examination of water II. Lactose-peptone media. J. Am. Chem. Soc. 1915, 37, 1949-1959; (b) Bigotto, A; Galasso, V.; Colonna, F. P.; Distefano, G.; Pappa;ardo, G. C.; Scarlata, G. Elctronic structure and photophysical properties of quinolinic anhydride, quinolinic thio anhydride, and N- methylquinolinimide. J. Chem. Soc. Perkin Trans. 2, 1978, 1194-1198.
Hinde, N. J.; Hall, C. D. Kinetics and mechanism of the formation of mono- and di-phthalate esters catalysted by titanium and tin alkoxides. J. Chem. Soc. Perkin Trans. 2, 1998, 5, 1249-1256.
a) Nagasaka, T.; Koseki, Y. Stereoselective Synthesis of Tilivalline J. Org. Chem. 1998, 63, 20, 6797-6801; b) Bogert, M. T.; Jouard, F. L. 3-Amino-o-phthalic acid and certain of its derivatives. J. Am. Chem. Soc. 1909, 31, 483-490.
Sircar, J. C.; Capiris, T.; Kesten, S. J.; Herzig, D. Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents. J. Med. Chem. 1981, 24, (6), 735-742.
Garden, S. J.; Torres, J. C.; Ferriera, A. A.; Silva, R. B.; Pinto, A. C. A modified sandmeyer methodology and the synthesis of (±)convolutamydine A. Tetrahedron Lett. 1997, 38, (9), 1501-1504.
Yen, V. Q.; Buu-Hoi, N. P.; Xuong, N. D. Fluorinated isatins and some of theis heterocyclic derivatives. J. Org. Chem. 1958, 23, 1858-1859.
Yen, V. Q.; Buu-Hoi, N. P.; Xuong, N. D. Fluorinated isatins and some of theis heterocyclic derivatives. J. Org. Chem. 1958, 23, 1858-1859.
(a) Jnaneshwara, G, K.; Bedekar, A. V.; Deshpande, V. H. Microwave assisted preparation of isatins and synthesis of (±)-convoluamydine-A. Synth. Commun. 1999, 29, 20, 3627-3634. (b) Yen, V. Q.; Buu-Hoi, N. P.; Xuong, N. D. Fluorinated isatins and some of theis heterocyclic derivatives. J. Org. Chem. 1958, 23, 1858-1859.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Yen, V. Q.; Buu-Hoi, N. P.; Xuong, N. D. Fluorinated isatins and some of theis heterocyclic derivatives. J. Org. Chem. 1958, 23, 1858-1859.
Waldmann, J. Prakt. Chem. 1937, 147, 338, 340.
Giovannini, E.; Portmann, P. Sur quelques derives de l''''oxindole et de I''''isative III Les acid isatine-carboxyliques-5-et-6. Helv. Chim. Acta. 1948, 31, 1382-1396.
Kiopman, G.; Noack, K. Electronic effects in Aromatic Metal Carbonyl Complexes, II, Infrared and Proton Magnetic Resonance Spectra of Substituted Benzoic Methyl Ester Tricarbonylchromium Derivatives. Inorg. Chem, 1968, 7, 579-584
Waldmann et al. J. Prakt. Chem. 1937, 147, 338-341.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Mitscher, L. A.; Wong, W.-C.; DeMeulenaere, T.; Sulko, J.; Drake, S. Heterocycles, 1981, 15, (2), 1017-1021.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Baker, W. R.; Wash, B.; Mitscher, L. A.; Kans, L. Indolo[2,1-b]quinazoline-6,12-dione antibacterial compounds and methods of use thereof. USP 5,441,955, 1995.
Manhas M. S., Amin S. G., Rao V. V. Hetercyclic Compounds; IX. A Facile Synthesis of Methaqualone and Analogs. Synthesis 1977, 309-310.
Clark, Wagner, J. Org. Chem. 1944, 9, 55, 61, 63.
Coyne, W.E; Cusic, J. W. J. Med. Chem. 1968, 11, 6, 1208-1213.
Coyne, W.E; Cusic, J. W. J. Med. Chem. 1968, 11, 6, 1208-1213.
Al-Talib, M.; Jochims, J. C.; Hamed, A.; Wang, Q.; Ismail, AbdE.-H.4(3H)-quinazolinones from the reaction of N-arylnitrilium salts with isocyanates. Synthesis, 1992, 7, 697-701.
Mori, M.; Uozumi, Y.; Shibasaki, M.; Incorporation of molecular nitrogen into organic compounds, III. Reaction of titanium-nitrogen complexes with acid halides and acid anhydrides. J. Organomet. Chem. 1990, 395, 3, 255-267.
(a) Lever, O. W.; Bell, L. N.; Hyman, C.; McGuire, H. M.; Ferone, R. J. Med. Chem. 1986, 29, 5, 665-670. (b) Ashley, J. N.; Collins, R. F.; Davis, M.; Sirett, N.-E. The chemotherapy of schistosomiasis. Part III, N-p-aminophenoxyalkyl-amide, -imides and sulphonamides. J. Chem. Soc. 1959, 3880-3894.
Muller, D.; Zeltser, I.; Bitan, G.; Gilon, C.; Building Units for N-Backbone Cyclic Peptides. J. Org. Chem, 1997, 62, 411-416.
Wang; Queenie, X.; Phanstiel, O. Total Synthesis of Acinetoferrin. J. Org. Chem, 1998, 63, 1491-1495.
Schinkel, A. H. The physiological function of drug-transporting P-glycoprotein. Semin Cancer Biol. 1997, 8, 161-170.
Gottesman, M. M.and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
Stein, W. D.; Cardarelli, C. O.; Pastan, I and Gottesman, M. M. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 1994, 45, 763-772.
Gottesman, M. M.and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
"Multiple drug resistance in cancer-cellular, molecular and clinical approaches." Edited by Clynes, M.
Hyde, S. C.; Emsley, P.; Hartshorn, M. J.; Mimmack, M. M.; Gileadi, U.; Pearce, S. R.; Gallagher, M. P.; Gill, G. R.; Hubbard, R. E. and Higgin, C. F. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 1990, 346, 362.
(a) Leie, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P.; Deeley, R. G. and Keppler, D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Bio. Chem. 1994, 269, 27807. (b) Muller, M.; Meijer, C.; Zaman, G. J.; Borst, P.; Scheper, R. J.; Mulder, N. H.; de Vries, E. G. and Jansen, P. L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Science. U.S.A. 1994, 91, 13033.
Jedlitschky, G.; Leie, I.; Buchholz, U.; Barnouin, K.; Kurz, G. and Keppler, D. Transport of glutathione, glucuronate and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Research, 1996, 56, 988.
Vezmar, M. and Georges, E. Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs. Biochem. Pharmaco. 2000, 59, 1245-1252.
(a) Heck , M. M. S.; Hittelman, W. N. and Earnshaw, W. C. Differential expression on DNA topoisomerase I and II during the eukaryotic cell cycle. Pro. Natl. Acad. Sci. U.S.A. 1988, 85, 1086-1090; (b) Barronco, S. C. Cellular and molecular effects of adriamycin on dividing and nondividing cells. Pharmac. Ther. 1984, 24, 303-319.
Andrew, B. J. Gene expression-dialogue with the cell cycle. Nature, 1992, 355, 393-394.
Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochemistry. 1989, 58, 351-375.
Gottesman, M. M.and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
Marquardt, D. and Center, M. S. Involvement of vacuolar H+-Adenosine triphosphatase activity in multidrug resistance in HL60 cells. J. Natl. Cancer Inst. 1991, 83, 1098-1102.
(a) Presant, C. A.; Kennedy, P.; Wiseman, C.; Gala, K and Myres, M. Verapamil plus adriamycin: a phase I-II clinical study. Proc. Am. Soc. Clin. Oncol. 1984, 3, 32. (b) Cantwell, B.; Carmichael, J.; Millward, M. J.; Chatterjee, M. and Harris A. L. Intermittent high dose tamixifen (HDT) with oral etoposide (EPO): Phase I and II clinical studies. Br. J. Cancer. 1989, 60, 450.
Hindenburg, A. A.; Baker, M. A.; Gleyer, E.; Stewart, V. J.; Case, N. and Taub, R. N. Effect of verapamil and oher agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res. 1987, 47, 1421-1425.
Tseng, S. Y. (曾詩韻) M. S. Dissertation, National Taiwan University, Taipei, R. O. C., 2000.
Felsenfeld, G.; Davis, D. D. R.; Rich, A. Formation of a three-stranded polynucleotide molecule. J. Am. Chem. Soc. 1957, 79, 2023-2024.
Cohen, J. S.; Hogan, M. E. The new genetic medicines. Scientific American, 1994, December, 50-55.
(a) Moser, H.
|